268 related articles for article (PubMed ID: 34975320)
1. GPR43 activation-mediated lipotoxicity contributes to podocyte injury in diabetic nephropathy by modulating the ERK/EGR1 pathway.
Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
Int J Biol Sci; 2022; 18(1):96-111. PubMed ID: 34975320
[No Abstract] [Full Text] [Related]
2. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
[No Abstract] [Full Text] [Related]
3. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
[TBL] [Abstract][Full Text] [Related]
5. Tangshen formula protects against podocyte apoptosis via enhancing the TFEB-mediated autophagy-lysosome pathway in diabetic nephropathy.
Wang Y; Peng L; Lu X; Zhang H; Zhao H; Zhao T; Yang L; Mao H; Ma F; Liu T; Li P; Zhan Y
J Ethnopharmacol; 2024 Apr; 324():117721. PubMed ID: 38199335
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic Acid Induces Podocyte Pyroptosis in Diabetic Nephropathy by an Increase of Egr1 Expression via Downregulation of EzH2.
Kim D; Ban KY; Lee GH; Jun HS
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373116
[TBL] [Abstract][Full Text] [Related]
7. Connexin 43‑autophagy loop in the podocyte injury of diabetic nephropathy.
Ji J; Zhao Y; Na C; Yang M; Zhu X; Shi H; Gan W; Zhang A
Int J Mol Med; 2019 Nov; 44(5):1781-1788. PubMed ID: 31545399
[TBL] [Abstract][Full Text] [Related]
8. Aspirin attenuates podocyte injury in diabetic rats through overriding cyclooxygenase-2-mediated dysregulation of LDL receptor pathway.
Ma KL; Liu L; Zhang Y; Wang GH; Hu ZB; Chen PP; Lu J; Lu CC; Gong TK; Gong YX; Liu BC
Int Urol Nephrol; 2019 Mar; 51(3):551-558. PubMed ID: 30604228
[TBL] [Abstract][Full Text] [Related]
9. Podocyte EGFR Inhibits Autophagy Through Upregulation of Rubicon in Type 2 Diabetic Nephropathy.
Li Y; Pan Y; Cao S; Sasaki K; Wang Y; Niu A; Fan X; Wang S; Zhang MZ; Harris RC
Diabetes; 2021 Feb; 70(2):562-576. PubMed ID: 33239448
[TBL] [Abstract][Full Text] [Related]
10. Integrated Network Pharmacology and Cellular Assay to Explore the Mechanisms of Selenized Tripterine Phytosomes (Se@Tri-PTs) Alleviating Podocyte Injury in Diabetic Nephropathy.
Zhu S; Liu Q; Chang Y; Luo C; Zhang X; Sun S
Curr Pharm Des; 2023; 29(38):3073-3086. PubMed ID: 37961864
[TBL] [Abstract][Full Text] [Related]
11. CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
Zuo F; Wang Y; Xu X; Ding R; Tang W; Sun Y; Wang X; Zhang Y; Wu J; Xie Y; Liu M; Wang Z; Yi F
Metabolism; 2024 Jan; 150():155724. PubMed ID: 37952690
[TBL] [Abstract][Full Text] [Related]
12. Lipotoxicity dysregulates the immunoproteasome in podocytes and kidneys in type 2 diabetes.
Lee HS; Suh JY; Kang BC; Lee E
Am J Physiol Renal Physiol; 2021 Apr; 320(4):F548-F558. PubMed ID: 33586497
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy.
Barutta F; Bellini S; Kimura S; Hase K; Corbetta B; Corbelli A; Fiordaliso F; Bruno S; Biancone L; Barreca A; Papotti MG; Hirsh E; Martini M; Gambino R; Durazzo M; Ohno H; Gruden G
Autophagy; 2023 Feb; 19(2):505-524. PubMed ID: 35659195
[TBL] [Abstract][Full Text] [Related]
14. Formyl peptide receptor 1 promotes podocyte injury through regulation of mitogen-activated protein kinase pathways.
Zhang J; Ding T; Tang D; Wang J; Huang P
Exp Biol Med (Maywood); 2022 Jan; 247(2):87-96. PubMed ID: 34565207
[TBL] [Abstract][Full Text] [Related]
15. High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway.
Zhang Y; Li H; Hao J; Zhou Y; Liu W
Exp Cell Res; 2014 Aug; 326(2):219-29. PubMed ID: 24768698
[TBL] [Abstract][Full Text] [Related]
16. Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy.
Salemkour Y; Yildiz D; Dionet L; 't Hart DC; Verheijden KAT; Saito R; Mahtal N; Delbet JD; Letavernier E; Rabant M; Karras A; van der Vlag J; Nijenhuis T; Tharaux PL; Lenoir O
J Am Soc Nephrol; 2023 Nov; 34(11):1823-1842. PubMed ID: 37678257
[TBL] [Abstract][Full Text] [Related]
17. HGF protected against diabetic nephropathy via autophagy-lysosome pathway in podocyte by modulating PI3K/Akt-GSK3β-TFEB axis.
Hou B; Li Y; Li X; Zhang C; Zhao Z; Chen Q; Zhang N; Li H
Cell Signal; 2020 Nov; 75():109744. PubMed ID: 32827692
[TBL] [Abstract][Full Text] [Related]
18. Liver X receptor activation induces podocyte injury via inhibiting autophagic activity.
Zhang Z; Tang S; Gui W; Lin X; Zheng F; Wu F; Li H
J Physiol Biochem; 2020 May; 76(2):317-328. PubMed ID: 32328877
[TBL] [Abstract][Full Text] [Related]
19. MAD2B promotes podocyte injury through regulating Numb-dependent Notch 1 pathway in diabetic nephropathy.
Li MR; Lei CT; Tang H; Yin XJ; Hao Z; Qiu Y; Xie YR; Zeng JY; Su H; Zhang C
Int J Biol Sci; 2022; 18(5):1896-1911. PubMed ID: 35342338
[No Abstract] [Full Text] [Related]
20. Sweroside attenuates podocyte injury and proteinuria in part by activating Akt/BAD signaling in mice.
Huang M; Yang Y; Chen Y; Li Y; Qin S; Xiao L; Long X; Hu K; Li Y; Ying H; Ding Y
J Cell Biochem; 2023 Nov; 124(11):1749-1763. PubMed ID: 37796169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
